Concepedia

Tiffany A. LaFortune

TA

10

Publications

1.1K

Citations

10

H-Index

2006

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Novartis Institutes for BioMedical Research

Novartis (Switzerland)

Tiffany A. LaFortune is an author at The University of Texas MD Anderson Cancer Center specializing in health sciences, matrix biology, and cell proliferation.

Top concepts

Publications per year

2006–2012

10

Publications

10

NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas

Ta-Jen Liu, Dimpy Koul, Tiffany A. LaFortune et al. · Molecular Cancer Therapeutics · 2009 · 249 citations · Full text

Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation <i>in vitro</i> and <i>in vivo</i>

Ta-Jen Liu, Tiffany A. LaFortune, Toshiyuki Honda et al. · Molecular Cancer Therapeutics · 2007 · 203 citations

Antitumor Activity of NVP-BKM120—A Selective Pan Class I PI3 Kinase Inhibitor Showed Differential Forms of Cell Death Based on p53 Status of Glioma Cells

Dimpy Koul, Jun Fu, Ruijun Shen et al. · Clinical Cancer Research · 2011 · 182 citations

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Reverses Mesenchymal to Epithelial Phenotype and Inhibits Metastasis in Inflammatory Breast Cancer

Dongwei Zhang, Tiffany A. LaFortune, Savitri Krishnamurthy et al. · Clinical Cancer Research · 2009 · 130 citations · Full text

Dasatinib-induced autophagy is enhanced in combination with temozolomide in glioma

Vanessa Milano, Yuji Piao, Tiffany A. LaFortune et al. · Molecular Cancer Therapeutics · 2009 · 120 citations

Rows per page

1–5 of 10